标题
Androgen Receptor-Directed Molecular Conjugates for Targeting Prostate Cancer
作者
关键词
-
出版物
Frontiers in Chemistry
Volume 7, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-05-28
DOI
10.3389/fchem.2019.00369
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Design, synthesis, and evaluation of the antiproliferative activity of hydantoin-derived antiandrogen-genistein conjugates
- (2018) Alex George et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Androgen receptor (AR) degradation enhancer ASC-J9 ® in an FDA-approved formulated solution suppresses castration resistant prostate cancer cell growth
- (2018) Max A. Cheng et al. CANCER LETTERS
- ASC-J9 ® suppresses prostate cancer cell invasion via altering the sumoylation-phosphorylation of STAT3
- (2018) WanYing Lin et al. CANCER LETTERS
- A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer
- (2018) Michael T. Schweizer et al. PLoS One
- Emerging Therapies in Metastatic Prostate Cancer
- (2018) Daniel W. Sonnenburg et al. Current Oncology Reports
- Molecular and cellular mechanisms of castration resistant prostate cancer (Review)
- (2018) Yiqiao Huang et al. Oncology Letters
- Targeting the androgen receptor (AR) with AR degradation enhancer ASC-J9 led to increase docetaxel sensitivity via suppressing the p21 expression
- (2018) Jie Luo et al. CANCER LETTERS
- Current status of androgen receptor-splice variant 7 inhibitor niclosamide in castrate-resistant prostate-cancer
- (2018) Navid Sobhani et al. INVESTIGATIONAL NEW DRUGS
- Alternative splicing in prostate cancer
- (2018) Alec Paschalis et al. Nature Reviews Clinical Oncology
- Molecules targeting the androgen receptor (AR) signaling axis beyond the AR-Ligand binding domain
- (2018) N. G. R. Dayan Elshan et al. MEDICINAL RESEARCH REVIEWS
- Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9 ® to Suppress Enzalutamide-resistant Prostate Cancer Progression
- (2017) Ronghao Wang et al. EUROPEAN UROLOGY
- 1,4-Substituted Triazoles as Nonsteroidal Anti-Androgens for Prostate Cancer Treatment
- (2017) Claudia Ferroni et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein Ligands
- (2017) Norihito Shibata et al. JOURNAL OF MEDICINAL CHEMISTRY
- Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?
- (2017) Ian Churcher JOURNAL OF MEDICINAL CHEMISTRY
- Antagonizing the Androgen Receptor with a Biomimetic Acyltransferase
- (2016) Yuchen Zhang et al. ACS Chemical Biology
- Small-Molecule PROTACS: New Approaches to Protein Degradation
- (2016) Momar Toure et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- ASC-J9® suppresses castration resistant prostate cancer progression via degrading the enzalutamide-induced androgen receptor mutant AR-F876L
- (2016) Ronghao Wang et al. CANCER LETTERS
- Multivalent Peptoid Conjugates Which Overcome Enzalutamide Resistance in Prostate Cancer Cells
- (2016) Y. Wang et al. CANCER RESEARCH
- A photodynamic bifunctional conjugate for prostate cancer: an in vitro mechanistic study
- (2016) Valentina Rapozzi et al. INVESTIGATIONAL NEW DRUGS
- Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells
- (2016) Simeng Wen et al. MOLECULAR CARCINOGENESIS
- Induced protein degradation: an emerging drug discovery paradigm
- (2016) Ashton C. Lai et al. NATURE REVIEWS DRUG DISCOVERY
- PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
- (2016) Kanak Raina et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer
- (2016) Chengfei Liu et al. Oncotarget
- Epigenetic modulators as therapeutic targets in prostate cancer
- (2016) Inês Graça et al. Clinical Epigenetics
- Small-Molecule-Mediated Degradation of the Androgen Receptor through Hydrophobic Tagging
- (2015) Jeffrey L. Gustafson et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Androgen Receptor Targeted Conjugate for Bimodal Photodynamic Therapy of Prostate Cancer in Vitro
- (2015) Valentina Rapozzi et al. BIOCONJUGATE CHEMISTRY
- AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer – results of two parallel first-in-human phase I studies
- (2015) A. Omlin et al. INVESTIGATIONAL NEW DRUGS
- ASC-J9 Suppresses Castration-Resistant Prostate Cancer Growth through Degradation of Full-length and Splice Variant Androgen Receptors
- (2015) Shinichi Yamashita et al. NEOPLASIA
- Optimisation of an immunohistochemistry method for the determination of androgen receptor expression levels in circulating tumour cells
- (2014) Jeffrey Cummings et al. BMC CANCER
- Niclosamide Inhibits Androgen Receptor Variants Expression and Overcomes Enzalutamide Resistance in Castration-Resistant Prostate Cancer
- (2014) C. Liu et al. CLINICAL CANCER RESEARCH
- A New Avenue toward Androgen Receptor Pan-antagonists: C2 Sterically Hindered Substitution of Hydroxy-propanamides
- (2014) Andrea Guerrini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selectively Targeting Prostate Cancer with Antiandrogen Equipped Histone Deacetylase Inhibitors
- (2013) Berkley E. Gryder et al. ACS Chemical Biology
- Discovery of AZD3514, a small-molecule androgen receptor downregulator for treatment of advanced prostate cancer
- (2013) Robert H. Bradbury et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Infiltrating Macrophages Promote Prostate Tumorigenesis via Modulating Androgen Receptor-Mediated CCL4-STAT3 Signaling
- (2013) L.-Y. Fang et al. CANCER RESEARCH
- AZD3514: A Small Molecule That Modulates Androgen Receptor Signaling and Function In Vitro and In Vivo
- (2013) S. A. Loddick et al. MOLECULAR CANCER THERAPEUTICS
- Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling
- (2013) T-H Lin et al. Cell Death & Disease
- Increased Infiltrated Macrophages in Benign Prostatic Hyperplasia (BPH)
- (2012) Xiaohai Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting Androgen Receptor Leads to Suppression of Prostate Cancer via Induction of Autophagy
- (2012) Qi Jiang et al. JOURNAL OF UROLOGY
- Design, synthesis and biological evaluation of nuclear receptor-degradation inducers
- (2011) Yukihiro Itoh et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Small-molecule androgen receptor downregulators as an approach to treatment of advanced prostate cancer
- (2011) Robert H. Bradbury et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- An androgenic steroid delivery vector that imparts activity to a non-conventional platinum(ii) metallo-drug
- (2010) Martin Huxley et al. DALTON TRANSACTIONS
- Conjugation of testosterone modifies the interaction of mono-functional cationic platinum(ii) complexes with DNA, causing significant alterations to the DNA helix
- (2010) Carlos Sanchez-Cano et al. DALTON TRANSACTIONS
- Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics
- (2008) Ashley R. Schneekloth et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started